Add To My Watchlist
View My Watchlist

Green Zone Power Rating: 13 High-Risk

Action to take: AVOID or SHORT
High-Risk stocks are expected to significantly underperform the market over the next 12 months. Short positions may capitalize on potentially negative price returns.
13
Price Based
Momentum
20
Size
12
Volatility
26
Fundamental Based
Value
45
Quality
35
Growth
59
Negative Factors (Bottom 20%)
Momentum: Stocks in downtrends and with significantly lagging momentum should be avoided.
Size: Stocks of the largest companies tend to lag the returns of otherwise equally-rated smaller companies.
Collapse Detail
NYSE%3ADOC charts & data provided by TradingView

Latest Insights on DOC

biotech stock to buy SIGA Technologies biotech REIT biotech value investor Novo Nordisk stock NVO Biotech Is Back: Watch This $100 Billion Trend
by Matthew Clark March 18, 2024 Money & Markets Daily
After a rough bear market, it looks like biotech stocks are charging higher. Here's a trend that points to more bullish action in 2024.
bitcoin halving Bitcoin’s 197% Rally Is Nothing Compared to What’s Next
by Matthew Clark March 14, 2024 Money & Markets Daily
Bitcoin's next halving event is happening in April, and cryptocurrencies are rallying ahead of it. Here's your best course of action now.
ICOL Colombia momentum ETF We Can Beat This Bullish Momentum ETF
by Matthew Clark March 11, 2024 Money & Markets Daily
The stock market is bullish, and more investors are looking to ride the rally to gains. Here's what our system says about this momentum ETF.
oil and gas stock DNOW Strong Bullish Momentum in an Overlooked Oil Sector
by Matthew Clark March 4, 2024 Investing
The oil and gas infrastructure market is growing at a steady clip. This "Strong Bullish" oil stock is set to benefit in a big way.
AI financial advisor Will AI Replace YOUR Financial Advisor?
by Adam O'Dell February 27, 2024 Money & Markets Daily
The AI economy is growing faster than most people can keep up with… What does that mean for financial advisors going forward?